Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 11, 2016 9:33 PM ET

Healthcare Providers and Services

Company Overview of City Of Hope

Company Overview

City of Hope, a nonprofit public benefit corporation, operates City of Hope National Medical Center (the Center), City of Hope Medical Foundation, and Beckman Research Institute of the City of Hope. The Center operates a 186-bed tertiary referral center primarily for the treatment of cancer, diabetes, and other life-threatening diseases in Duarte, California. The company was founded in 1913 and is based in Duarte, California.

1500 East Duarte Road

Duarte, CA 91010

United States

Founded in 1913



Key Executives for City Of Hope

Chief Executive Officer and President
Chief Financial Officer
Age: 52
Chief Operating Officer and Executive Vice President
Chief Scientific Officer and Provost
Senior Vice President of Research Operations
Compensation as of Fiscal Year 2015.

City Of Hope Key Developments

Ravi Salgia Joins City of Hope as Chair of Medical Oncology

Medical oncologist and researcher Ravi Salgia, M.D., Ph.D., has joined City of Hope as a professor and chair in the Department of Medical Oncology & Therapeutics Research. He will play a key leadership role in the expansion of clinical programs at City of Hope's Duarte campus and in its clinics throughout Southern California, as well as enhance the integration of therapeutics with research. At City of Hope, Salgia will work closely with faculty to support both basic research and clinical studies aimed at discovering new cancer treatments. Beyond his role as the Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology, he will also serve as associate director for clinical sciences in the institution's comprehensive cancer center. His expertise in developing new cancer treatments in the laboratory, testing them in clinical trials and speeding them to patients fits perfectly with City of Hope's mission.

Tara Immuno-Oncology, LLC Signs Licensing Agreement with City of Hope

Tara Immuno-Oncology, LLC has acquired licenses from City of Hope for the development of p53MVA and a Salmonella-based therapy targeting Indoleamine 2,3-Dioxygenase (shIDO-ST). Under the terms of the transaction, Tara will pay City of Hope upfront and payments in excess of $10 million, in addition to commercial royalties for the exclusive licenses.

Glenn D. Steele Jr. Joins City of Hope's Board of Directors

Renowned health care leader Glenn D. Steele Jr., M.D., Ph.D., the recent past president and chief executive officer of Geisinger Health System, will join the City of Hope board of directors beginning Jan. 1, 2016. Steele is currently chair of xG Health Solutions.

Similar Private Companies By Industry

Company Name Region
Premier Anesthesia, LLC United States
BiologicTx, LLC United States
Comprehensive Therapy Services, Inc. United States
Employment Support Services, Inc. United States
Straight & Narrow, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact City Of Hope, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at